PNPLA3 and metabolic dysfunction-associated steatotic liver disease: In our study, the PNPLA3 risk allele group (rs738409, GG + GC) had a higher proportion of NAFLD cases than the non-risk allele group (rs738409, CC) (19.9% [2110/10,616] vs. 16.0% [840/5241]; Table 1).